Green Cross Holdings Corporation (KRX:005257)

Market Cap	694.19B
Revenue (ttm)	2.40T
Net Income (ttm)	127.58B
Shares Out	n/a
EPS (ttm)	2,832.40
PE Ratio	5.44
Forward PE	n/a
Dividend	500.00 (1.99%)
Ex-Dividend Date	Dec 27, 2024

Volume	405
Average Volume	1,134
Open	25,400
Previous Close	25,400
Day's Range	25,000 - 25,400
52-Week Range	18,300 - 73,900
Beta	0.68
RSI	42.84
Earnings Date	Feb 10, 2026

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005257